Schonfeld Strategic Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$87.1K	Buy	+35,414	New	+$119K	﹤0.01%	1908
2022 Q1	–	Sell	-4,230	Closed	-$200K	–	2736
2021 Q4	$200K	Sell	4,230 -129,500	-97%	-$7.77M	﹤0.01%	1730
2021 Q3	$9.69M	Buy	133,730 +114,630	+600%	+$8.29M	0.1%	264
2021 Q2	$1.6M	Sell	19,100 -51,151	-73%	-$3.37M	0.02%	784
2021 Q1	$3.4M	Buy	+70,251	New	+$3.81M	0.04%	535
2020 Q2	–	Sell	-18,735	Closed	-$244K	–	1374
2020 Q1	$244K	Buy	+18,735	New	+$234K	0.02%	836

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schonfeld Strategic Advisors's NBP Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026: 35,414 shares worth $87.1K. The stake represents ﹤0.01% of the portfolio and ranks #1908 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in NBP as recently as Q4 2021.

Schonfeld Strategic Advisors first reported a position in NBP in Q1 2020 and has held it in 6 quarters since. The position peaked at $9.69M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Schonfeld Strategic Advisors held 35,414 shares of NovaBridge Biosciences American Depositary Shares worth $87.1K as of Q1 2026.
NovaBridge Biosciences American Depositary Shares was a new Schonfeld Strategic Advisors position in Q1 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1908 holding.
Schonfeld Strategic Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and has held it in 6 quarters since.
Schonfeld Strategic Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $9.69M in Q3 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.